देश: इटली
भाषा: अंग्रेज़ी
स्रोत: HMA (Heads of Medicines Agencies)
marbofloxacin 100 mg
Laboratorios Syva SA
QJ01MA93
marbofloxacin
Cattle Food, Pigs Females, Pigs Food
2012-10-24
1 _[Version 7.3.2, 10/2011] _ ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Marboquinol 100 mg/ml solution for injection for cattle and pigs (sows) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: ACTIVE SUBSTANCE: Marbofloxacin 100 mg EXCIPIENTS: Metacresol 2 mg Monothioglycerol 1 mg Disodium edetate 0.1 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection Clear, yellowish solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and pigs (sows). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In cattle: - Treatment of respiratory infections caused by susceptible strains of _Histophilus somni, Mannheimia _ _haemolytica,_ _Pasteurella multocida_ and _ Mycoplasma bovis_. - Treatment of acute forms of mastitis induced by marbofloxacin-susceptible _Escherichia coli_ strains, during lactation. In pigs (sows): - Treatment of Postpartum Dysgalactiae Syndrome, PDS (Metritis Mastitis Agalactia Syndrome) caused by marbofloxacin-susceptible bacterial strains. 4.3 CONTRAINDICATIONS Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross resistance Do not use in animals with known hypersensitivity to the active substance or to any other quinolone or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE 3 SPECIAL PRECAUTIONS FOR USE IN ANIMALS Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones should be rese पूरा दस्तावेज़ पढ़ें
1 _[Version 7.3.2, 10/2011] _ ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Marboquinol 100 mg/ml solution for injection for cattle and pigs (sows) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: ACTIVE SUBSTANCE: Marbofloxacin 100 mg EXCIPIENTS: Metacresol 2 mg Monothioglycerol 1 mg Disodium edetate 0.1 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection Clear, yellowish solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and pigs (sows). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In cattle: - Treatment of respiratory infections caused by susceptible strains of _Histophilus somni, Mannheimia _ _haemolytica,_ _Pasteurella multocida_ and _ Mycoplasma bovis_. - Treatment of acute forms of mastitis induced by marbofloxacin-susceptible _Escherichia coli_ strains, during lactation. In pigs (sows): - Treatment of Postpartum Dysgalactiae Syndrome, PDS (Metritis Mastitis Agalactia Syndrome) caused by marbofloxacin-susceptible bacterial strains. 4.3 CONTRAINDICATIONS Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross resistance Do not use in animals with known hypersensitivity to the active substance or to any other quinolone or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE 3 SPECIAL PRECAUTIONS FOR USE IN ANIMALS Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones should be rese पूरा दस्तावेज़ पढ़ें